Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
4.880
-0.230 (-4.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
Elicio Therapeutics Employees
Elicio Therapeutics had 32 employees as of December 31, 2023. The number of employees increased by 9 or 39.13% compared to the previous year.
Employees
32
Change (1Y)
9
Growth (1Y)
39.13%
Revenue / Employee
n/a
Profits / Employee
-$1,463,844
Market Cap
52.59M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 32 | 9 | 39.13% |
Dec 31, 2022 | 23 | -1 | -4.17% |
Dec 31, 2021 | 24 | 2 | 9.09% |
Dec 31, 2020 | 22 | - | - |
Related Stocks
Company Name | Employees |
---|---|
CareCloud | 3,600 |
Celularity | 120 |
Mural Oncology | 117 |
Invivyd | 95 |
Connect Biopharma Holdings | 81 |
Shattuck Labs | 75 |
Spero Therapeutics | 46 |
Modular Medical | 40 |
ELTX News
- 9 days ago - Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024 - GlobeNewsWire
- 5 weeks ago - Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 6 weeks ago - Elicio Therapeutics Presents Updated Translational Data from ELI-002 Phase 1 AMPLIFY-7P Study at the Society for Immunotherapy of Cancer (“SITC”) 2024 Annual Meeting - GlobeNewsWire
- 7 weeks ago - Elicio Therapeutics to Present Clinical Data at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting and Stand Up to Cancer (SU2C) Innovation Summit - GlobeNewsWire
- 2 months ago - Elicio Therapeutics Reports Inducement Grants - GlobeNewsWire
- 3 months ago - Elicio Therapeutics Announces Three Upcoming Presentations Focused on its Lymph Node Targeted, mKRAS-Specific Amphiphile Vaccines - GlobeNewsWire
- 4 months ago - Elicio Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - Elicio Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Updates - GlobeNewsWire